Balance Sheet for CollPlant Biotechnologies Ltd. (CLGN)

$ 10.30   0.48 (+4.89%) Volume: 3.69k 10:56 AM EDT May 29, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 3,791 5,354 5,126 987 1,362
Restrictable Cash 12 154 - - -
Marketable Securities - - - - -
Accounts Receivable 79 516 102 779 368
Loans Receivable - - - - -
Other Receivables 186 229 392 8 16
Receivables 265 745 627 950 469
Inventories, Raw Materials - - - - -
Inventories, Work in Progress 422 264 - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 466 550 - - -
Inventories, Other 888 814 201 127 -
Inventories, Adjustments & Allowances - - - - -
Inventories 888 814 201 127 -
Prepaid Expenses 84 105 494 34 362
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 5,040 7,172 6,449 2,098 2,192
Land and Improvements - - - - -
Buildings and Improvement 2,271 1,517 934 750 267
Machinery, Furniture and Equipment 2,876 2,744 2,801 2,509 2,388
Construction in Progress - - - - -
Fixed Assets, Other 3,215 - - - -
Fixed Assets, Total 8,362 4,261 3,735 3,259 2,655
Gross Fixed Assets 8,362 4,261 3,735 3,259 2,655
Accumulated Depreciation (2,818) (2,854) (2,705) (2,217) (1,986)
Net Fixed Assets 5,544 1,407 1,031 1,042 669
Intangibles - 338 418 424 441
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 168 155 145 145 145
Total Non-Current Assets 5,712 1,580 1,620 1,654 1,273
Total Assets 10,752 8,752 8,069 3,752 3,466
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable (90) 613 841 1,769 961
Short Term Debt 479 22 - - -
Notes Payable - - - - -
Accrued Expenses 2,126 628 574 - -
Accrued Liabilities 2,126 628 574 - -
Deferred Revenues 942 970 - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - - -
Total Current Liabilities 3,457 2,233 1,415 1,769 961
Long Term Debt 3,139 22 3,636 - -
Deferred Income Tax - 980 - - -
Other Non-Current Liabilities (5,416) 1,077 404 641 -
Minority Interest - - - - -
Capital Lease Obligations 3,139 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 3,207 1,099 4,041 641 -
Total Liabilities 6,664 3,332 5,456 2,411 961
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 4,088 5,420 2,613 1,341 2,505
Common Par 2,368 1,580 1,438 834 683
Additional Paid in Capital 69,949 60,905 51,349 41,560 36,044
Cumulative Translation Adjustments (969) (969) - - -
Retained Earnings (67,260) (56,096) (50,173) (41,052) (34,222)
Treasury Stock - - - - -
Other Equity Adjustments (969) (969) - - -
Total Capitalization 9,572 5,442 6,250 1,341 2,505
Total Equity 4,088 5,420 2,613 1,341 2,505
Total Liabilities & Shareholder's Equity 10,752 8,752 8,069 3,752 3,466
Cash Flow (11,164) (6,248) (5,990) (7,193) (4,810)
Working Capital 1,583 4,939 5,034 328 1,232
Free Cash Flow (7,164) (2,049) (5,274) (5,165) (4,070)
Invested Capital 4,088 5,442 6,250 1,341 2,505
Shares Outstanding - Common Class Only 5,671 3,815 3,336 2,161 1,776
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 5,671 3,815 3,336 2,161 1,776
Total Common Shares Outstanding 5,671 3,815 3,336 2,161 1,776
Treasury Shares - - 18 - -
Basic Weighted Shares Outstanding 4,986 4,385 2,664 2,012 1,693
Diluted Weighted Shares Outstanding 4,986 4,385 2,664 2,012 1,693